4 Healthcare Stock Stories for Thursday Investment Wellness

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

BG Medicine (NASDAQ:BGMD): Current price $1.72

BG has announced the publication of two studies that demonstrate the clinical utility of repeated galectin-3 testing used as a tool in the assessment of patients with heart failure. The evaluations, which taken together entailed over 3,300 subjects, show that periodic evaluation of galectin-3 levels can aid clinicians in identifying those at greater risk of unplanned hospital admission and cardiovascular morbidity and mortality. BG is a diagnostics firm that concentrates on the development and commercialization of novel cardiovascular tests.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

bg

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business